How Pharmacists Are Fighting COVID-19 Misinformation
MAY 15, 2020 | GRANT M. GALLAGHER
Segment Description: Elizabeth Leung, PharmD,MSCI, BCPS-AQ ID, Co-lead, St. Michael’s Hospital Antimicrobial Stewardship Program,
University of Toronto talks about the work being done by the Society of Infectious Disease Pharmacists (SIDP), one of Contagion’s strategic partners.
More coverage featuring pharmacists on the frontlines:
Contagion Editor in Chief Jason Gallagher, PharmD, discusses the new authorization for Remdesivir.
Jeannette Bouchard, PharmD, infectious disease pharmacy fellow, University of South Carolina and Prisma Health, discusses how ID pharmacists are taking on new responsibilities and working collaboratively to respond to COVID-19.
Ryan W. Stevens, PharmD, BCIDP, discusses the risks associated with convalescent plasma and highlights what clinicians should know about using convalescent plasma among patients with COVID-19.
Lucas Schulz, PharmD, BCPS, AQ-ID, clinical coordinator, infectious diseases, University of Wisconsin Health, discusses how he is preparing for COVID-19 as a clinical pharmacist working in Wisconsin.
Thomas Dilworth, PharmD, pharmacy coordinator, infectious diseases, Aurora St. Luke’s Medical Center, provides a recap of ACEIs, ARBs, and NSAIDs in patients with COVID-19.
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512